Bristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement

Bristol-Myers Squibb and Concerto HealthAI Sign Cancer Real World Data Agreement

Source: 
BioSpace
snippet: 

BMS inked a multi-year strategic agreement with Concerto HealthAI, which focuses on oncology-specific Real-World Data (RWD) and advanced AI for Real-World Evidence (RWE) generation.